Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis.

Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis.

The major known genetic risk factors in multiple sclerosis reside in the major histocompatibility complex (MHC) region. Although there is strong evidence implicating MHC class II alleles and CD4(+) T cells in multiple sclerosis pathogenesis, possible contributions from MHC class I genes and CD8(+) T...

Full description

Bibliographic Details
Main Authors:	Friese, M, Jakobsen, K, Friis, L, Etzensperger, R, Craner, M, McMahon, R, Jensen, LT, Huygelen, V, Jones, E, Bell, J, Fugger, L
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis
by: McMahon, R, et al.
Published: (2011)

Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis.
by: McMahon, R, et al.
Published: (2011)

Autoreactive CD8+ T cells in multiple sclerosis: A new target for therapy?
by: Friese, M, et al.
Published: (2005)

Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
by: Friese, M, et al.
Published: (2005)

Dissection of the multiple sclerosis associated DR2 haplotype.
by: Etzensperger, R, et al.
Published: (2008)

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
by: Vergo, S, et al.
Published: (2011)

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model
by: Vergo, S, et al.
Published: (2011)

Acid sensing ion channel 1 contributes to axonal degeneration in autoimmune CNS inflammation and provides a novel target for neuroprotection in multiple sclerosis
by: Craner, M, et al.
Published: (2008)

The immunology of multiple sclerosis
by: Attfield, KE, et al.
Published: (2022)

Joint-specific and systemic autoreactivity in the development of inflammatory arthritis.
by: Fugger, L
Published: (2000)

IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain.
by: Tzartos, J, et al.
Published: (2011)

Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
by: Friese, M, et al.
Published: (2007)

Misfiring in multiple sclerosis: cerebellar channelopathy, a potential novel target?
by: Craner, M, et al.
Published: (2012)

From genes to function: the next challenge to understanding multiple sclerosis
by: Fugger, L, et al.
Published: (2009)

From genes to function: the next challenge to understanding multiple sclerosis.
by: Fugger, L, et al.
Published: (2009)

Pathogenic CD8(+) T cells in multiple sclerosis.
by: Friese, M, et al.
Published: (2009)

T cells and microglia as drivers of multiple sclerosis pathology
by: Friese, M, et al.
Published: (2007)

T cells and microglia as drivers of multiple sclerosis pathology.
by: Friese, M, et al.
Published: (2007)

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.
by: Tzartos, J, et al.
Published: (2008)

Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
by: Rongzeng Liu, et al.
Published: (2022-09-01)

The value of animal models for drug development in multiple sclerosis.
by: Friese, M, et al.
Published: (2006)

The value of animal models for drug development in multiple sclerosis
by: Friese, M, et al.
Published: (2006)

Autoreactive TCD8+ lymphocytes in patients with chronic myeloid leukemia in association with HLA and adenovirus infection
by: Sergio E. Rivera-Pirela, et al.
Published: (2016-05-01)

Multiple sclerosis: MHC associations and therapeutic implications.
by: Holmes, S, et al.
Published: (2005)

Humanized mouse models for organ-specific autoimmune diseases.
by: Friese, M, et al.
Published: (2006)

A molecule basis for the HLA association in rheumatoid arthritis.
by: Andersson, E, et al.
Published: (2000)

Axonal injury in reverse.
by: Craner, M, et al.
Published: (2011)

Interleukin-17 expression in multiple sclerosis
by: Tzartos, J, et al.
Published: (2006)

Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responses.
by: Fridkis-Hareli, M, et al.
Published: (2001)

Sustained effects on immune cell subsets and autoreactivity in multiple sclerosis patients treated with oral cladribine
by: Rikke Holm Hansen, et al.
Published: (2024-02-01)

HLA variation and disease
by: Dendrou, C, et al.
Published: (2018)

Adaptive Immunity and the Risk of Autoreactivity in COVID-19
by: Rhiane Moody, et al.
Published: (2021-08-01)

MHC II molecules in inflammatory diseases: interplay of qualities and quantities.
by: Friese, M, et al.
Published: (2005)

NK cell autoreactivity and autoimmune diseases
by: Alessandro ePoggi, et al.
Published: (2014-02-01)

Autoreactive T-Lymphocytes in Inflammatory Skin Diseases
by: Wolf-Henning Boehncke, et al.
Published: (2019-05-01)

Identification of autoreactive B cells with labeled nucleosomes
by: Vincent Gies, et al.
Published: (2017-04-01)

T Cell-Mediated Autoimmune Disease Due to Low-Affinity Crossreactivity to Common Microbial Peptides (DOI:10.1016/j.immuni.2009.01.009)
by: Harkiolaki, M, et al.
Published: (2009)

T Cell-Mediated Autoimmune Disease Due to Low-Affinity Crossreactivity to Common Microbial Peptides (vol 30, pg 348, 2009)
by: Harkiolaki, M, et al.
Published: (2009)

T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides.
by: Harkiolaki, M, et al.
Published: (2009)

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.
by: Dendrou, C, et al.
Published: (2013)